Table 4 |
|
|
Serious adverse events |
|
|
Adalimumab |
Placebo |
|
|
|
|
Appendicitis1,4 |
Gastritis2,4 |
|
Tendonitis2,4 |
|
|
Sequence Adalimumab-Adalimumab |
Sequence Placebo- Adalimumab |
|
Pain2,4 |
Colitis3,4 |
|
Vertigo3,4 |
Pyelonephritis1,4 |
|
|
|
|
1Judged as possibly related; 2Judged as not related; 3Judged as probably not related; 4Outcome: recovered completely. There were no events of malignancy, demyelinating disorders or deaths. |
|
|
Horneff et al. Arthritis Research & Therapy 2012 14:R230 doi:10.1186/ar4072 |
|
